# UPLIZNA

- **Website:** <https://uplizna.com>
- **Primary alias:** `uplizna.com`

## Description

UPLIZNA is a prescription treatment from Amgen for adults living with certain antibody-positive autoimmune conditions. Its active ingredient is inebilizumab-cdon. The medicine is indicated for adults with neuromyelitis optica spectrum disorder (NMOSD) who test positive for anti-aquaporin-4 antibodies, immunoglobulin G4-related disease (IgG4-RD), and generalized myasthenia gravis (gMG) who test positive for anti-AChR or anti-MuSK antibodies. The website notes that UPLIZNA is not known to be safe or effective in children.

The official UPLIZNA patient website provides condition-specific information, treatment details, Important Safety Information, a Medication Guide, and access to prescribing information. It also introduces a patient support program and shares patient experiences. The site describes UPLIZNA as a treatment designed to fit patients’ lifestyles and states that, after two startup infusions, it is administered twice per year. UPLIZNA was FDA-approved for adults with gMG in 2025. Patients can explore resources for NMOSD, IgG4-RD, and gMG and review safety information with their healthcare team.

## Industries

- ⛑ Health
- ⛑ Biotechnology and Pharmaceuticals _(under Health)_

## Logos & icons

- logo _(primary)_ — PNG, SVG — [download](https://cdn.brandfetch.io/idMngXlc0_/w/820/h/336/theme/dark/logo.png?c=1bxid64Mup7aczewSAYMX&t=1791486663320)

## Colors

| Name | Hex | Theme |
| --- | --- | --- |
| Vivid Violet | #823f98 | accent |
| Science Blue | #0063c3 | dark |
| White | #ffffff | light |

## Fonts

- Helvetica Neue — asset _(custom)_
- Roboto-Regular — asset _(custom)_

---

_Source: <https://brandfetch.com/uplizna.com>_
_See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._